Antiretroviral therapy (ART) with a generic fixed-dose combination (FDC) of stavudine (d4T)/lamivudine (3TC)/nevirapine (NVP) is widely used in developing countries. The clinical data of this FDC among very advanced HIV-infected patients is limited.
Manosuthi, W., Chimsuntorn, S., Likanonsakul, S., & Sungkanuparph, S. (2007). Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm 3. AIDS Research and Therapy, 4. https://doi.org/10.1186/1742-6405-4-6